This update of the 2013 clinical practice guideline provides clinicians with guidance
regarding the use of aprepitant and palonosetron for the prevention of acute chemotherapy …

This guideline provides clinicians caring for children with an approach to assessing the
acute emetogenic potential of antineoplastic therapies. It was developed by an international …

This clinical practice guideline provides an approach to the treatment of breakthrough
chemotherapy‐induced nausea and vomiting (CINV) and the prevention of refractory CINV …

PURPOSE: To assess thiopurine S-methyltransferase (TPMT) phenotype and genotype in
patients who were intolerant to treatment with mercaptopurine (MP) or azathioprine (AZA) …

Objectives To determine the incidence and causes of adverse drug events (ADEs) and
potential ADEs in hospitalized children, and to examine the consequences of these events …

This guideline provides an approach to the prevention of acute antineoplastic‐induced
nausea and vomiting (AINV) in children. It was developed by an international, inter …

BACKGROUND To the authors' knowledge there is little information available regarding the
effectiveness of standard antiemetic therapy among cancer patients who receive …

OBJECTIVES. This study was conducted to determine the impact of a computerized
physician order entry system with substantial decision support on the incidence and types of …

A critical step towards reducing the incidence of extinction is to identify and rank the species
at highest risk, while implementing protective measures to reduce the risk of extinction to …

Background Catheter‐associated blood stream infections (CABSI) are frequent
complications encountered with cancer treatment. In order to understand which factors might …